Literature DB >> 21701939

Pharmaceutical patents, R&D incentives and access to new drugs: new ways of progress at the crossroad.

Fernando Antoñanzas, Carmelo Juárez-Castelló, Roberto Rodríguez-Ibeas.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21701939     DOI： 10.1007/s10198-011-0336-9

Source DB:  PubMed          Journal:  Eur J Health Econ        ISSN： 1618-7598


× No keyword cloud information.
  6 in total

Review 1.  Differential pricing for pharmaceuticals: reconciling access, R&D and patents.

Authors:  Patricia M Danzon; Adrian Towse
Journal:  Int J Health Care Finance Econ       Date:  2003-09

2.  Should the patent system for new medicines be abolished?

Authors:  J A DiMasi; H G Grabowski
Journal:  Clin Pharmacol Ther       Date:  2007-11       Impact factor: 6.875

3.  The quantity and quality of worldwide new drug introductions, 1982-2003.

Authors:  Henry G Grabowski; Y Richard Wang
Journal:  Health Aff (Millwood)       Date:  2006 Mar-Apr       Impact factor: 6.301

4.  Developing drugs for developing countries.

Authors:  David B Ridley; Henry G Grabowski; Jeffrey L Moe
Journal:  Health Aff (Millwood)       Date:  2006 Mar-Apr       Impact factor: 6.301

5.  Product-line extensions and pricing strategies of brand-name drugs facing patent expiration.

Authors:  Song Hee Hong; Marvin D Shepherd; David Scoones; Thomas T H Wan
Journal:  J Manag Care Pharm       Date:  2005 Nov-Dec

6.  The cost of pushing pills: a new estimate of pharmaceutical promotion expenditures in the United States.

Authors:  Marc-André Gagnon; Joel Lexchin
Journal:  PLoS Med       Date:  2008-01-03       Impact factor: 11.069
  6 in total
  2 in total

Review 1.  Defining and Measuring the Affordability of New Medicines: A Systematic Review.

Authors:  Fernando Antoñanzas; Robert Terkola; Paul M Overton; Natalie Shalet; Maarten Postma
Journal:  Pharmacoeconomics       Date:  2017-08       Impact factor: 4.981

2.  EMA Priority Medicines scheme (PRIME): will more paying-for-performance agreements be needed due to immature data?

Authors:  F Antoñanzas; C A Juárez-Castelló; R Rodríguez-Ibeas
Journal:  Eur J Health Econ       Date:  2018-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.